MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway

被引:15
作者
Xiang, Xin-xin [1 ]
Liu, Yong-liang [2 ]
Kang, Yi-fan [3 ]
Lu, Xiang [3 ]
Xu, Kai [3 ]
机构
[1] Shandong Univ, Zibo Cent Hosp, Ctr Translat Med, Zibo 255036, Peoples R China
[2] Shandong Univ, Zibo Cent Hosp, Dept Otolaryngol, Zibo 255036, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Otorhinolaryngol Head & Neck Surg, Wuhan 430030, Peoples R China
基金
中国国家自然科学基金;
关键词
INTENSITY-MODULATED RADIOTHERAPY; ACTIN-BINDING PEPTIDES; RECOMBINANT SCINDERIN; PROLIFERATION; MULTICENTER; METASTASIS; EXPRESSION; PROTEINS; RELEASE; CELLS;
D O I
10.1038/s41419-022-04871-0
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mex-3 RNA Binding Family Member A (MEX3A) is an RNA-binding protein that plays complex and diverse roles in the development of various malignancies. However, its role and mechanism in nasopharyngeal carcinoma (NPC) remain undefined and were therefore evaluated in this study. By analyzing Gene Expression Omnibus data and using tissue microarrays, we found that MEX3A is significantly upregulated in NPC and negatively associated with prognosis. Notably, MEX3A depletion led to decreased cell proliferation, invasion, and migration, but increased apoptosis in NPC cells in vitro, while inhibiting tumor growth in vivo. Using whole-transcript expression arrays and bioinformatic analysis, we identified scinderin (SCIN) and miR-3163 as potential downstream targets of MEX3A in NPC. The regulatory mechanisms of MEX3A, SCIN and miR-3163 were further investigated using rescue experiments. Importantly, SCIN depletion and miR-3163 inhibition reversed and rescued the oncogenic effects of MEX3A, respectively. Moreover, NF-kappa B signaling inhibition reversed the oncogenic effects of both SCIN and MEX3A. In summary, our results demonstrate that MEX3A may promote NPC development and progression via the miR-3163/SCIN axis by regulating NF-kappa B signaling, thus providing a potential target for NPC treatment.
引用
收藏
页数:12
相关论文
共 50 条
[21]   Upregulation of PNCK Promotes Metastasis and Angiogenesis via Activating NF-κB/VEGF Pathway in Nasopharyngeal Carcinoma [J].
Chen, Xiaochuan ;
Weng, Youliang ;
Li, Ying ;
Fu, Wankai ;
Huang, Zongwei ;
Pan, Yuhui ;
Hong, Wenquan ;
Lin, Wanzun ;
Lin, Xiandong ;
Qiu, Sufang .
JOURNAL OF ONCOLOGY, 2022, 2022
[22]   MEX3A promotes triple negative breast cancer proliferation and migration via the PI3K/AKT signaling pathway [J].
Jiang, Shujun ;
Meng, Lingjia ;
Chen, Xinye ;
Liu, Hongmei ;
Zhang, Junfeng ;
Chen, Fei ;
Zheng, Jie ;
Liu, Hui ;
Wang, Feng ;
Hu, Junyan ;
Li, Zhe .
EXPERIMENTAL CELL RESEARCH, 2020, 395 (02)
[23]   AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway [J].
Ye, Runyi ;
Liu, Dongwei ;
Guan, Hongyu ;
AiErken, NiJiati ;
Fang, Zeng ;
Shi, Yawei ;
Zhang, Yunjian ;
Wang, Shenming .
LIFE SCIENCES, 2021, 286
[24]   LncRNA HOXA-AS3 promotes gastric cancer progression by regulating miR-29a-3p/LTβR and activating NF-κB signaling [J].
Qu, Feng ;
Zhu, Bin ;
Hu, Yi-Lin ;
Mao, Qin-Sheng ;
Feng, Ying .
CANCER CELL INTERNATIONAL, 2021, 21 (01)
[25]   MiR-155 affects osteosarcoma cell proliferation and invasion through regulating NF-κB signaling pathway [J].
Lu, S. ;
Liao, Q-S ;
Tang, L. .
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (22) :7633-7639
[26]   Folic acid receptor a facilitates nasopharyngeal carcinoma via ERK1/2/NF-κB signaling pathway [J].
Liu, Zhibiao ;
Jin, Xin ;
Pi, Wen ;
Liu, Shouhou .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07) :10367-10374
[27]   miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway [J].
Zhao, Liang ;
Zhang, Yubao .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 457 (03) :370-377
[28]   Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway [J].
Chen, Zhaohui ;
Zhou, Lijie ;
Liu, Xuehan ;
Wang, Longwang ;
Kazobinka, Gallina ;
Zhang, Xiaoping ;
Hou, Teng .
LABORATORY INVESTIGATION, 2018, 98 (09) :1225-1236
[29]   ROC1 promotes the malignant progression of bladder cancer by regulating p-IκBα/NF-κB signaling [J].
Wu, Qi ;
Zhou, Xiaoqing ;
Li, Peng ;
Ding, Mao ;
You, Shengjie ;
Xu, Zhaoyu ;
Ye, Junjie ;
Chen, Xuedong ;
Tan, Mingyue ;
Wang, Jun ;
Wang, Wei ;
Qiu, Jianxin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)
[30]   CircCRIM1 promotes nasopharyngeal carcinoma progression via the miR-34c-5p/FOSL1 axis [J].
He, Weifeng ;
Zhou, Xiangqi ;
Mao, Yini ;
Wu, YangJie ;
Tang, Xiyang ;
Yan, Sijia ;
Tang, Sanyuan .
EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)